NYSE · Healthcare
TELEFLEX INC (TFX)
As-reported financials and recent SEC filings for TELEFLEX INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.99B
Net income
$-905.6M
Net margin
-45.4%
Diluted EPS
$-20.25
ROE
-29.0%
P/E (TTM)
2164.3×
Market cap
$5.75B
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.99B | $1.70B | $1.71B | $2.79B | $2.81B |
| Gross profit | $1.12B | $1.04B | $1.04B | $1.53B | $1.55B |
| Operating income | $118.4M | $103.7M | $258.7M | $499.7M | $628.1M |
| Net income | $-905.6M | $69.7M | $356.3M | $363.1M | $485.4M |
| Diluted EPS | $-20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-26
View on EDGAR →8-K2026-06-15
View on EDGAR →42026-06-09
View on EDGAR →42026-06-09
View on EDGAR →32026-06-09
View on EDGAR →8-K2026-06-09
View on EDGAR →8-K2026-06-02
View on EDGAR →8-K2026-06-01
View on EDGAR →Go deeper on TFX
Search TELEFLEX INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.